Automatic remote monitoring: milestones reached, paths to pave.

Automatic remote Home Monitoring™ is a transforming technology in the evolution of cardiovascular implantable electronic devices (CIEDs).1 However, innovations are usually greeted guardedly, especially ones which demand changes in clinical habits. When and how these should be applied are obvious questions to physicians and patients alike. Automatic remote monitoring (RM)—with its finer distinctions of operation, i.e. remote follow-up vs. remote (or continuous) monitoring2—has been no exception. During a decade after its introduction, clinical implementation has progressed from initial curiosity and occasional use, through studies demonstrating reliability and clinical applications, to several large-scale prospective trials.3 Their results have been impressive and remarkably consistent, improving upon current standard of care and opening new avenues for exploration. Notably, when directly compared with recommended conventional in-person follow-up (the TRUST control arm providing this first evaluation), Home Monitoring™ secured greater retention of patients and also improved punctuality and adherence to scheduled evaluations.4,5 The safe and effective replacement of the bulk of ‘routine’ in-clinic evaluations has a huge implication for resource utilization. This effect was coupled with capability for same day discovery of problems (even when asymptomatic), with appropriate technology, and clinical infrastructure in place.6 This was an outlandish concept even a few years ago when advance to 5.7 months with remote management was considered ‘early’.7 The most obvious application of RM is for detection of system dysfunction.8 Most triggered alerts demanded reprogramming. Correct programming itself imparts survival benefit.9 Needs are anticipated to change over time. Remote monitoring has significant value under these conditions, e.g. to reduce inappropriate shocks.10 Although safety concerns underpinned original post-implant follow-up schedules, e.g. for assessing pacing thresholds, integrity of components, and charging capacitors, these issues now belong to a different era. Current generation devices require no such maintenance, have …

[1]  R. Ricci Disease management: atrial fibrillation and home monitoring. , 2013, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[2]  B. Wilkoff,et al.  Cost efficiency and reimbursement of remote monitoring: a US perspective. , 2013, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[3]  W. Abraham Disease management: remote monitoring in heart failure patients with implantable defibrillators, resynchronization devices, and haemodynamic monitors. , 2013, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[4]  C. Lau,et al.  Remote monitoring of cardiac implantable devices in the Asia-Pacific. , 2013, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[5]  Richard Sutton,et al.  Remote monitoring as a key innovation in the management of cardiac patients including those with implantable electronic devices. , 2013, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[6]  N. Varma Automatic remote home monitoring of implantable cardioverter defibrillator lead and generator function: a system that tests itself everyday. , 2013, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[7]  R. Ricci,et al.  Workflow, time and patient satisfaction from the perspectives of home monitoring. , 2013, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[8]  Panos Vardas,et al.  Remote monitoring costs, benefits, and reimbursement: a European perspective. , 2013, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[9]  H. Burri Remote follow-up and continuous remote monitoring, distinguished. , 2013, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[10]  P. Brugada,et al.  Role of home monitoring in children with implantable cardioverter defibrillators for Brugada syndrome. , 2013, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[11]  M. Santini Remote monitoring and the twin epidemics of atrial fibrillation and chronic heart failure. , 2013, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[12]  P. Mabo,et al.  Current clinical evidence for remote patient management. , 2013, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[13]  B. Stambler,et al.  Same-day discovery of implantable cardioverter defibrillator dysfunction in the TRUST remote monitoring trial: influence of contrasting messaging systems , 2012, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[14]  Dominique Lacroix,et al.  A randomized study of remote follow-up of implantable cardioverter defibrillators: safety and efficacy report of the ECOST trial , 2012, European heart journal.

[15]  Wojciech Zareba,et al.  Reduction in inappropriate therapy and mortality through ICD programming. , 2012, The New England journal of medicine.

[16]  Christophe Leclercq,et al.  2012 EHRA/HRS expert consensus statement on cardiac resynchronization therapy in heart failure: implant and follow-up recommendations and management. , 2012, Heart rhythm.

[17]  Jagmeet P. Singh,et al.  Multidisciplinary care of patients receiving cardiac resynchronization therapy is associated with improved clinical outcomes. , 2012, European heart journal.

[18]  Jagmeet P. Singh Advances in electrical therapy for heart failure: papers from the International ADVANCE CRT Summit. , 2012, Heart rhythm.

[19]  Maurizio Marzegalli,et al.  Remote Monitoring Reduces Healthcare Use and Improves Quality of Care in Heart Failure Patients With Implantable Defibrillators: The Evolution of Management Strategies of Heart Failure Patients With Implantable Defibrillators (EVOLVO) Study , 2012, Circulation.

[20]  Andrew S. Mugglin,et al.  Early Detection of an Underperforming Implantable Cardiovascular Device Using an Automated Safety Surveillance Tool , 2012, Circulation. Cardiovascular quality and outcomes.

[21]  M. Borggrefe,et al.  Intrathoracic Impedance Monitoring, Audible Patient Alerts, and Outcome in Patients With Heart Failure , 2011, Circulation.

[22]  B. Wilkoff,et al.  Device features for managing patients with heart failure. , 2011, Heart failure clinics.

[23]  A. Boyle,et al.  The CONNECT (Clinical Evaluation of Remote Notification to Reduce Time to Clinical Decision) trial: the value of wireless remote monitoring with automatic clinician alerts. , 2011, Journal of the American College of Cardiology.

[24]  L. Stevenson,et al.  Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial , 2011, The Lancet.

[25]  H. Krumholz,et al.  Telemonitoring in patients with heart failure. , 2010, The New England journal of medicine.

[26]  P. Heidenreich,et al.  Long-Term Outcome After ICD and CRT Implantation and Influence of Remote Device Follow-Up: The ALTITUDE Survival Study , 2010, Circulation.

[27]  K. Ellenbogen,et al.  Downloadable Software Algorithm Reduces Inappropriate Shocks Caused by Implantable Cardioverter-Defibrillator Lead Fractures: A Prospective Study , 2010, Circulation.

[28]  R. Schweikert,et al.  Efficacy and Safety of Automatic Remote Monitoring for Implantable Cardioverter-Defibrillator Follow-Up: The Lumos-T Safely Reduces Routine Office Device Follow-Up (TRUST) Trial , 2010, Circulation.

[29]  Sana M. Al-Khatib,et al.  Combined heart failure device diagnostics identify patients at higher risk of subsequent heart failure hospitalizations: results from PARTNERS HF (Program to Access and Review Trending Information and Evaluate Correlation to Symptoms in Patients With Heart Failure) study. , 2010, Journal of the American College of Cardiology.

[30]  Hongyan Qiao,et al.  Clinical benefits of remote versus transtelephonic monitoring of implanted pacemakers. , 2009, Journal of the American College of Cardiology.

[31]  L. Jordaens,et al.  Analysis of 57,148 Transmissions by Remote Monitoring of Implantable Cardioverter Defibrillators , 2009, Pacing and clinical electrophysiology : PACE.

[32]  Christophe Leclercq,et al.  2012 EHRA/HRS expert consensus statement on cardiac resynchronization therapy in heart failure: implant and follow-up recommendations and management. , 2012, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.